Table 2.

Reasons for switching from other anticoagulants to apixaban

Reasons for switching from warfarin to apixaban (n = 2038)
Poor INR control	36.4%
INR control and adverse events	0.9%
Physician's decision	25.0%
Patient's preference	10.3%
Dietary restrictions	7.3%
Others	10.6%
Unknown	9.4%
INR values at the time of switching from warfarin (n = 760)
<1.6	61.2%
1.6 to <2.0	8.3%
2.0 to <2.6	2.9%
2.6 to <3.0	2.4%
≥3.0	7.1%
Unknown	18.1%
Reasons for switching from other NOACs (n = 776)
Physician's decision	33.1%
Efficacy	15.3%
Safety concerns	5.9%
Blood test results	5.3%
Adverse events	23.3%
Gastrointestinal symptoms	10.0%
Bleeding	6.1%
Patient characteristics	19.8%
Renal function	12.9%
Age	4.9%
Patient's preference	15.7%
Others	8.1%

Abbreviations: INR, international normalized ratio; NOACs, non‐vitamin K oral anticoagulants.